Dr. Constance C. Blunt, M.D.
Medical Oncology (Medical Oncology Physician)
4950 Essen Ln Ste 500
Baton Rouge, LA 70809
Who else practices at this address →
East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Texas A & M University System, Hsc, College of Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 200
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Texas A & M University System, Hsc, College of Medicine
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
LA license 207962 -
Internal Medicine Physician
TX license BP10043536
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baton Rouge General Medical Center Baton Rouge, LA
- Womans Hospital Baton Rouge, LA
- Opelousas General Health System Opelousas, LA
Medical groups
- Mary Bird Perkins Cancer Center (100 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 200
- Services billed
- 16,518
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 192 | 59 |
| Established patient office or other outpatient visit, 30-39 minutes | 48 | 35 |
| Injection of drug or substance under skin or into muscle | 20 | 11 |
| New patient office or other outpatient visit, 60-74 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Baton Rouge, LA | 178 |
| Eliquis (apixaban) Other prescribers in Baton Rouge, LA | 31 |
| Abiraterone Acetate | 25 |
| Dexamethasone Other prescribers in Baton Rouge, LA | 25 |
| Ondansetron Odt (ondansetron) Other prescribers in Baton Rouge, LA | 22 |
| Hydroxyurea Other prescribers in Baton Rouge, LA | 20 |
| Acyclovir Other prescribers in Baton Rouge, LA | 20 |
| Tramadol Hcl Other prescribers in Baton Rouge, LA | 17 |
| Prednisone Other prescribers in Baton Rouge, LA | 16 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Baton Rouge, LA | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 48 payments worth $983 in total to this clinician.
| Pfizer Inc. | $217 |
|---|---|
| Daiichi Sankyo Inc. | $108 |
| Array Biopharma Inc | $97.57 |
| AstraZeneca Pharmaceuticals LP | $94.26 |
| Novartis Pharmaceuticals Corporation | $74.51 |
| Stemline Therapeutics Inc. | $43.26 |
| Tersera Therapeutics LLC | $39.50 |
| AbbVie Inc. | $37.61 |
| Food and Beverage | $940 |
|---|---|
| Education | $43.25 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 25, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.